Rigel Pharmaceuticals Inc
RIGL· Nasdaq
RIGLRigel Pharmaceuticals Inc
Released May 7, 2019, after the close
10-Q filed May 7, 2019, 37 days after period end · 0001558370-19-004244
| Metric | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 |
|---|---|---|---|---|
| Revenue | $12.62M | — | $3.58M | — |
| Net Income | -$17.60M | -$24.39M | -$15.31M | — |
| EPS Diluted |
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
| -$0.11 |
| -$0.17 |
| -$0.13 |
| -$0.19 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
